Log in

LON:SISScience in Sport Share Price, Forecast & News

GBX 32.50
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
30.60
Now: GBX 32.50
32.95
50-Day Range
31
MA: GBX 33.09
37
52-Week Range
27
Now: GBX 32.50
64.75
Volume238,330 shs
Average Volume29,236 shs
Market Capitalization£43.91 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes and sports enthusiasts under the SiS brand name in the United Kingdom, rest of the European Union, Australia, and internationally. Its principal product range SiS GO energy powders, isotonic gels, energy bars and hydration tablets; and SiS REGO, a range of spectrum recovery products; and WHEY20, a protein product. The company sells its products through independent sports retailers, grocers, high street chains, and third-party online retailers, and international sales distributors, as well as e-commerce platform. Science in Sport plc was founded in 1992 and is based in London, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1282-440980

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£50.57 million
Cash FlowGBX 4.33 per share
Book ValueGBX 37.40 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£43.91 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SIS News and Ratings via Email

Sign-up to receive the latest news and ratings for SIS and its competitors with MarketBeat's FREE daily newsletter.

Science in Sport (LON:SIS) Frequently Asked Questions

How has Science in Sport's stock been impacted by COVID-19 (Coronavirus)?

Science in Sport's stock was trading at GBX 41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SIS shares have decreased by 20.7% and is now trading at GBX 32.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Science in Sport?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science in Sport in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Science in Sport.

How were Science in Sport's earnings last quarter?

Science in Sport PLC (LON:SIS) issued its earnings results on Wednesday, March, 21st. The company reported ($7.70) earnings per share for the quarter, beating analysts' consensus estimates of ($8.20) by $0.50. The business had revenue of $15.62 million for the quarter. View Science in Sport's earnings history.

What price target have analysts set for SIS?

1 equities research analysts have issued 12-month price objectives for Science in Sport's shares. Their forecasts range from GBX 80 to GBX 80. On average, they expect Science in Sport's share price to reach GBX 80 in the next twelve months. This suggests a possible upside of 146.2% from the stock's current price. View analysts' price targets for Science in Sport.

Has Science in Sport been receiving favorable news coverage?

Media coverage about SIS stock has trended negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Science in Sport earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the next few days. View the latest news about Science in Sport.

Who are some of Science in Sport's key competitors?

What other stocks do shareholders of Science in Sport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival (CCL), Bellway (BWY), British American Tobacco (BTI), Boohoo Group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC).

Who are Science in Sport's key executives?

Science in Sport's management team includes the following people:
  • Mr. Stephen N. Moon, CEO & Exec. Director
  • Ms. Elizabeth J. Lake, CFO & Exec. Director (Age 51)
  • Dr. James Morton, Group Chief Scientific Officer

What is Science in Sport's stock symbol?

Science in Sport trades on the London Stock Exchange (LON) under the ticker symbol "SIS."

How do I buy shares of Science in Sport?

Shares of SIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Science in Sport's stock price today?

One share of SIS stock can currently be purchased for approximately GBX 32.50.

How big of a company is Science in Sport?

Science in Sport has a market capitalization of £43.91 million and generates £50.57 million in revenue each year.

What is Science in Sport's official website?

The official website for Science in Sport is www.scienceinsport.com.

How can I contact Science in Sport?

Science in Sport's mailing address is 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom. The company can be reached via phone at +44-1282-440980.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.